Aleksander Krag Selected Research

profermin

11/2013	Profermin is efficacious in patients with active ulcerative colitis--a randomized controlled trial.
4/2012	Safety and efficacy of Profermin® to induce remission in ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleksander Krag Research Topics

Disease

67	Fibrosis (Cirrhosis) 11/2022 - 07/2006
29	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022 - 01/2013
20	Liver Diseases (Liver Disease) 01/2022 - 11/2009
15	Ascites 06/2021 - 12/2007
14	Hemorrhage 01/2021 - 11/2008
12	Portal Hypertension 01/2021 - 11/2008
11	Inflammation (Inflammations) 06/2022 - 06/2012
9	Hepatorenal Syndrome 01/2017 - 12/2007
8	Non-alcoholic Fatty Liver Disease 06/2022 - 01/2019
7	End Stage Liver Disease 01/2020 - 11/2011
6	Hepatic Encephalopathy 01/2020 - 10/2012
6	Varicose Veins (Varicose Vein) 01/2020 - 03/2010
5	Crohn Disease (Crohn's Disease) 01/2022 - 12/2013
5	Infections 10/2021 - 01/2013
5	Ulcerative Colitis 01/2021 - 04/2012
4	Colitis 01/2022 - 04/2012
4	Fatty Liver 10/2021 - 01/2019
4	Chronic Hepatitis C 06/2021 - 01/2012
4	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 01/2012
4	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 05/2015 - 07/2006
3	Bacterial Infections (Bacterial Infection) 01/2021 - 04/2019
3	Peritonitis 01/2021 - 06/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2019 - 10/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2016
2	Insulin Resistance 01/2022 - 12/2016
2	Acute-On-Chronic Liver Failure 01/2021 - 08/2015
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2020 - 02/2018
2	Alcoholic Hepatitis 01/2018 - 09/2015
2	Abdominal Pain (Pain, Abdominal) 01/2017 - 01/2017
2	Hepatitis C 12/2016 - 01/2012
2	Esophageal and Gastric Varices (Esophageal Varices) 08/2010 - 09/2009
1	Binge Drinking 01/2022
1	Cholelithiasis 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 10/2021
1	Obesity 10/2021
1	Hepatitis B 10/2021
1	Cholestasis 10/2021

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2013
12	TerlipressinIBA 01/2020 - 12/2007
10	CollagenIBA 03/2022 - 01/2013
9	Proteins (Proteins, Gene)FDA Link 06/2021 - 09/2014
8	Complement C3 (C3 Complement)IBA 01/2022 - 01/2013
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 03/2010
6	Rifaximin (L 105)FDA Link 01/2021 - 01/2014
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
5	Collagen Type III (Type III Collagen)IBA 10/2021 - 10/2015
5	SodiumIBA 01/2019 - 11/2008
4	Alanine Transaminase (SGPT)IBA 06/2021 - 05/2015
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2021 - 01/2018
4	Dobutamine FDA LinkGeneric 01/2020 - 02/2009
4	Matrix Metalloproteinases (MMPs)IBA 11/2019 - 09/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 11/2011
4	Vasoconstrictor AgentsIBA 09/2010 - 12/2007
3	LipidsIBA 10/2021 - 12/2016
3	Transaminases (Aminotransferases)IBA 06/2021 - 01/2018
3	CytokinesIBA 12/2020 - 06/2012
3	C-Reactive ProteinIBA 12/2020 - 06/2012
3	Propranolol (Inderal)FDA LinkGeneric 01/2016 - 07/2006
3	Antiviral Agents (Antivirals)IBA 01/2015 - 01/2012
3	Vasopressins (Vasopressin)IBA 04/2011 - 12/2007
2	nasIBA 06/2022 - 03/2022
2	Dextran SulfateIBA 01/2022 - 11/2019
2	Ethanol (Ethyl Alcohol)IBA 01/2022 - 01/2019
2	CholesterolIBA 01/2022 - 01/2020
2	4-(3-chlorophenylsulfanyl)piperidineIBA 01/2020 - 01/2017
2	Complement C4 (Complement Component 4)IBA 11/2019 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2019 - 01/2013
2	EpitopesIBA 06/2019 - 01/2013
2	BilirubinIBA 01/2018 - 05/2015
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2016
2	Collagen Type V (Type V Collagen)IBA 01/2017 - 05/2015
2	AlbuminsIBA 01/2017 - 09/2012
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2017 - 09/2009
2	Complement C5 (Complement 5)IBA 01/2017 - 05/2015
2	Adrenergic Agents (Adrenergic Drugs)IBA 03/2014 - 01/2014
2	Lactulose (Duphalac)FDA LinkGeneric 01/2014 - 10/2012
2	proferminIBA 11/2013 - 04/2012
2	EndotoxinsIBA 01/2013 - 11/2011
1	Indicators and Reagents (Reagents)IBA 11/2022
1	Laminin (Merosin)IBA 01/2022
1	laminin gamma 1IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	EnzymesIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	CopperIBA 10/2021
1	IronIBA 10/2021
1	Fibrillar CollagensIBA 10/2021
1	Ointments (Pastes)IBA 10/2021
1	ApolipoproteinsIBA 06/2021
1	Aspartic Acid (Aspartate)FDA Link 06/2021

Therapy/Procedure

14	Therapeutics 01/2021 - 02/2009
8	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2021 - 02/2009
7	Liver Transplantation 10/2021 - 02/2009
2	Transjugular Intrahepatic Portasystemic Shunt 01/2019 - 01/2013
2	Ligation 01/2018 - 08/2012
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2022